Summary & Overview
HCPCS G0147: Automated Cervical/Vaginal Cytopathology Screening
HCPCS Level II code G0147 represents automated screening cytopathology smears of the cervix or vagina performed under physician supervision. Nationally, this code captures activities tied to automated Pap test screening workflows and laboratory-based cytology services, which are central to cervical cancer screening programs and related quality measures. The code matters for payers and providers because it distinguishes automated technical screening services from manual review and diagnostic cytopathology, affecting billing pathways and oversight expectations. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and service setting, typical payer coverage patterns, and the kinds of benchmarks and policy considerations that influence how automated cytology screening is billed and reimbursed. Where available, the publication outlines common modifiers and operational implications; if specific payer policy details are absent, it is noted as unavailable. The document is intended for health plan analysts, billing professionals, lab administrators, and clinicians who need a clear, national-level summary of what G0147 denotes, how it fits into laboratory workflows, and what to expect in payer interactions and claims adjudication.
Billing Code Overview
HCPCS Level II code G0147 describes screening cytopathology smears of the cervix or vagina performed by an automated system under physician supervision. The service type is automated cytopathology screening, typically performed in laboratory or pathology service settings such as hospital laboratories, independent diagnostic laboratories, or outpatient pathology labs. This code denotes the technical screening process using automated equipment with oversight by a physician.
Clinical & Coding Specifications
Clinical Context
A 34-year-old woman presents to an outpatient gynecology clinic for routine cervical cancer screening. A clinician collects a cervical/vaginal specimen using a cervical brush or spatula during a speculum exam. The specimen is prepared as a cytology smear and routed to the laboratory where an automated screening system performs primary cytologic evaluation under the supervision of a pathologist or cytotechnologist. The automated system scans and classifies smears, flags abnormal fields for review, and the supervising physician reviews and signs out results. Typical workflow steps include specimen accessioning, automated slide processing and imaging, technical review by laboratory staff, physician review for flagged or abnormal cases, result reporting to the ordering clinician, and integration into the patient’s electronic medical record. Typical site of service is an outpatient clinic or independent clinical laboratory; specimen collection occurs in the clinic and the automated screening is performed in the clinical laboratory.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting the physician’s professional interpretation/supervision separate from the technical laboratory component |
TC |